Company Details
| Sector | PHARMACEUTICALS |
| Address | 197-A The Mall Rawalpindi Pakistan |
| Auditor | KPMG Taseer Hadi & Co. Chartered Accountants |
| Registrar | CDC Share Registrar Services Limited, CDC House, 99-B, Block-B, S.M.C.H.S, Main Shahrah Faisal, Karachi |
| Website | www.bfbio.com |
| Fiscal Year | |
| Details |
Details
"BF Biosciences Limited (""BFBL""@ ""Company""@ or the ""Issuer"") was incorporated as an unlisted public limited company under the Companies Ordinance@ 1984 (now Companies Act@ 2017) in 2006@ and operates within the pharmaceutical industry. BFBL is a 80%:20% joint venture between Ferozsons Laboratories Limited and the Bagó Group of Argentina. The Company's core operations involve the import@ manufacturing@ marketing and distribution of pharmaceutical products."
Company Announcements
| Date/Time | Announcement |
|---|---|
| 30/10/2024 12:27:14 | EPS = 1.82 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 181.587 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 115.273 FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 30/09/2024 |